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96 Session: Disease & Treatmentvital to maintain the balance of bone homeostasis. Our early article elucidated
myricitrin could protect from osteoporotic bone mass reduction via reducing reac-
tive oxygen species (ROS) in osteoblastic bone formation; however, the influence
of osteoclastogenesis by myricitrin is still unclear. Here, we exhibited that myrici-
trin could decrease the TRAP positive cell number significantly in a dose-depen-
dent manner during osteoclast maturation, but it had no effect to pre-osteoclast
proliferation. Consistently, osteoclast maturation markers, and the bone resorp-
tive pits number and area were decreased. Taken together, myricitrin could inhibit
osteoclastogenesis.
http://dx.doi.org/10.1016/j.jot.2016.06.087297
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Background: Telomere length plays a vital role in genomic stability and shortened
telomeres may cause genomic instability and carcinogenesis. Mitochondria exert a
potential role in energy metabolism, free radical production, apoptosis, and may
be involved in cancer progression. Both telomere length and alteration of mito-
chondrial DNA (mtDNA) copy number have been proposed as biomarkers for several
cancers. Nevertheless, few studies have examined the association of telomere
length and mtDNA copy number in musculoskeletal tumours. This study aimed to
examine telomere length and mtDNA copy number in peripheral blood leukocytes,
neoplastic tissues, and non-neoplastic adjacent tissues of patients with musculo-
skeletal tumours. The second objective of this study was to investigate the rela-
tionship of telomere length and mtDNA copy number in musculoskeletal tumours.
Subjects and Methods: Peripheral blood leukocytes (nZ41), neoplastic tissues
(nZ46), and non-neoplastic adjacent tissues (nZ32) were obtained from patients
with musculoskeletal tumours. Relative telomere length and relative mtDNA copy
number were evaluated by quantitative real-time polymerase chain reaction.
Results: Relative telomere length in neoplastic tissues was significantly shorter than
that in non- neoplastic adjacent tissues (p Z 0.001). Shorter relative telomere
length in neoplastic tissues compared to non-neoplastic tissues was observed in
female and male (pZ 0.018 and pZ 0.019, respectively). In addition, the relative
telomere length in malignant tissues was significantly decreased as compared with
that in adjacent non-neoplastic tissues (p Z 0.016). While the relative telomere
length in malignant tissues seemed to be lower than that in benign tissues, there
was no significant difference. The relative telomere length in peripheral blood
leukocytes was not correlated with that in neoplastic tissues. In contrast, relative
mtDNA copy number in neoplastic tissues was not different when compared to
that in non-neoplastic adjacent tissues. The relative mtDNA copy number in periph-
eral blood leukocytes was not associated with that in neoplastic tissues. Interest-
ingly, relative mtDNA copy number in neoplastic tissues was significantly higher
than that in peripheral blood leukocytes (p < 0.001). Further analysis showed that
there was a negative association between relative telomere length and mtDNA
copy number in patients with musculoskeletal tumours (rZ -0.306; pZ 0.104).
Discussion and Conclusion: Relative telomere length in neoplastic tissues was
significantly shorter than that in non-neoplastic adjacent tissues, suggesting that
neoplastic tissues (especially malignant tissues) may undergo several cell divisions
which could lead to progressively shorter telomeres. This finding demonstrated
that relative mtDNA copy number in tissues was significantly higher than that in pe-
ripheral blood leukocytes. The explanation of this finding could be due to speci-
ficity of mtDNA copy number in different types of tissues. The relative telomere
length is inversely associated with the relative mtDNA copy number, indicating
that telomere length attrition and mtDNA alteration are necessary events in
musculoskeletal tumour progression.
http://dx.doi.org/10.1016/j.jot.2016.06.088340
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Background: Primary and metastatic cancers that affect bone are frequently asso-
ciated with severe and intractable pain. Bone cancer pain has been reported with
unique mechanisms and is resistant to morphine treatment. Previous studies have
indicated that change of m-opioid receptor (MOR) expression may be involved in
the pathogenesis of bone cancer pain. In addition, neuron-restrictive silencerfactor (NRSF) has been recently reported to modulate transcription of the MOR
gene. The present study elucidates the regulatory mechanisms of MOR and its po-
tential to effect bone cancer pain.
Methods: Using a sarcoma inoculated murine model, pain behaviours that repre-
sent continuous or breakthrough pain were evaluated. Immunofluorescent staining
was used to check the expression of NRSF in the dorsal root ganglion (DRG).
Reverse transcription-polymerase chain reaction (RT-PCR) and Western blot anal-
ysis were used to quantify expression of NRSF at the transcriptional and transla-
tional levels, respectively. Additionally, chromatin immunoprecipitation assays
were used to detect NRSF binding to the promoter of MOR. Furthermore, NRSF
was genetically knocked out by antisense oligodeoxynucleotide (AS-ODN), and
the expression of MOR and the effect of morphine were subsequently analysed.
Results: Our results indicated that in a sarcoma murine model, expression of NRSF
is upregulated in the DRG neurons and the expression of NRSF mRNA is significantly
negatively correlated with expression of MOR mRNA. Additionally, chromatin
immunoprecipitation analysis revealed that NRSF binding to the neuron-restrictive
silencer element within the promoter area of the MOR gene is significantly pro-
moted with a hypo-acetylation state of histone H3. Furthermore, genetically
knocking down of NRSF with AS-ODN rescued the expression of MOR, with potenti-
ation of system morphine analgesia.
Discussion and Conclusion: The present results suggest that in sarcoma induced
bone cancer pain, NRSF induced downregulation of MOR is involved in the reduction
of morphine analgesia. Epigenetically, up-regulation of MOR could substantially
improve the effect of system delivery of morphine. The results indicate that NRSF
plays an important role in the modulation of MOR transcription and may represent
a novel analgesic target for bone cancer pain. What should be noted is that the
expression of opioid receptors are not only regulated at the transcriptional level,
but are also controlled by extensive post-transcriptional processing. Further studies
are needed at both the preclinical and clinical levels to develop pharmacological
therapy and to effectively block/relieve bone cancer pain with the goal of
increasing the functional status and quality of life of humans with bone cancer pain.
http://dx.doi.org/10.1016/j.jot.2016.06.089367
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Introduction: MicroRNAs (miRNAs) play important roles in the regulation of target
gene expression to coordinate a broad spectrum of biological processes. There is
increasing evidence that multiple miRNAs serve as important regulators of osteoblast
differentiation and bone formation. Significantly, recent studies have discovered that
miR-214, miR-103a, and miR-103, were sensitive to mechanical stimulation to regu-
late osteoblast differentiation or proliferation. However, functional roles of miRNAs
in mechano-transduction in bone formation and further mechanisms in vivo and in vi-
tro have not been well-characterised and, therefore, particularly remain to be eluci-
dated. This study aimed to identify specific miRNAs and their regulatory roles in the
process of bone loss induced by mechanical unloading condition.
SubjectsandMethods:Bonespecimensfrom70osteoporotic individualswithbedridden
states were collected. Twenty-one-month mice and HLU mice were used as the osteo-
porosis model. The RPM machine as an unloading model was used to culture cells.
Results: We assessed the expression of miRNAs involved in bone formation in bone
specimens from 70 osteoporotic individuals with bedridden states in clinical set-
tings. The expression of miR-138-5p altered with bedridden time and was nega-
tively correlated with the expression of the bone formation marker genes ALP in
bedridden women and men. Moreover, consistent results were found in bone tissue
and ALP positive cells in hind limb unloading (HLU) and 20-month aging mice. In
addition, we found that high miR-138-5p expression increased gradually and ALP
activity decreased in osteoblasts after RPM treatment for 12, 24, 48 hours. Target
prediction analysis tools and luciferase activity were used to confirm microtubule
actin crosslinking factor 1 (MACF1) as a direct target of miR-138-5p, and miR-138-
5p inhibited MACF1 expression and osteoblast differentiation in vitro. We treated
mouse preosteoblast MC3T3-E1 cells with antagomir-138-5p and cultured cells un-
der RPM condition. The results indicated that miR-138-5p functions as a mechani-
cal unloading sensitive miRNA and plays a negative role in RPM-induced osteoblast
differentiation reduction. Predominantly, we found an inhibitory role of miR-138-
5p in regulating the bone formation in HLU mice and in vivo pre-treatment with
antagomir-138-5p partly recovered the bone loss caused by hind limb unloading.
Discussion and Conclusion: Taken together, these results suggest that in vivo in-
hibition of miR-138-5p by antimiR-138-5p could represent a potential therapeutic
strategy for ameliorating bone loss.
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